- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Daratumumab/rHuPH20
Total 386 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Testosterone Greater Than 150 ng/dLUnited States
-
Halozyme TherapeuticsCompletedType 1 Diabetes MellitusUnited States
-
Universidad Nacional Autonoma de MexicoUnknownBurning Mouth SyndromeMexico
-
Second Affiliated Hospital of Soochow UniversityThe Affiliated Hospital of Xuzhou Medical UniversityRecruitingRelapsed/Refractory Multiple MyelomaChina
-
H. Lee Moffitt Cancer Center and Research InstituteJanssen Scientific Affairs, LLCActive, not recruitingMultiple MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Not yet recruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeUnited States
-
ViiV HealthcareGlaxoSmithKlineNot yet recruiting
-
Baxter Healthcare CorporationHalozyme TherapeuticsCompleted
-
University Hospital, LilleJanssen Pharmaceutica N.V., BelgiumNot yet recruiting
-
ViiV HealthcareRecruiting
-
Scripps HealthTerminatedPancreatic Adenocarcinoma Non-resectableUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States
-
National University Hospital, SingaporeJanssen, LP; International Myeloma FoundationUnknownRelapse and / or Refractory MyelomaSingapore, Hong Kong, Taiwan, Korea, Republic of
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedVarious Advanced CancerUnited States, Belgium, France, Germany, Japan, Korea, Republic of, Mexico, Netherlands, Spain, Taiwan, United Kingdom
-
Fondazione Italiana Linfomi - ETSJanssen-Cilag S.p.A.RecruitingPlasmablastic LymphomaItaly
-
Syros PharmaceuticalsCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States, France
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type 1United States
-
Baxalta now part of ShireCompletedPrimary Immunodeficiency Diseases (PID)United States
-
Human Genome Sciences Inc.CompletedMultiple MyelomaUnited States, Canada, Australia, India
-
Augusta UniversityJanssen Scientific Affairs, LLCNot yet recruitingMultiple Myeloma | Renal FailureUnited States
-
Mayo ClinicRecruitingAL AmyloidosisUnited States
-
PETHEMA FoundationJanssen PharmaceuticaRecruitingHigh-Risk de Novo Multiple MyelomaSpain
-
Alliance Foundation Trials, LLC.Takeda; Janssen Scientific Affairs, LLC; Celgene CorporationActive, not recruitingMyeloma, MultipleUnited States
-
Halozyme TherapeuticsCompleted
-
Nektar TherapeuticsCompletedMultiple Myeloma | Non-Hodgkin Lymphoma | Indolent Non-Hodgkin LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsActive, not recruitingMultiple MyelomaUnited States
-
The First Affiliated Hospital of Soochow UniversityNot yet recruiting
-
Alfred Chung, MDAbbVie; Janssen PharmaceuticalsRecruitingAL Amyloidosis | Light Chain (AL) Amyloidosis | Systemic Light Chain DiseaseUnited States
-
University Hospital, LilleActive, not recruiting
-
Weill Medical College of Cornell UniversityJanssen Scientific Affairs, LLCRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Germany, Netherlands, Spain
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type IIUnited States
-
TakedaActive, not recruitingMultiple MyelomaUnited States, Spain, Belgium, Israel
-
University of Alabama at BirminghamJanssen Scientific Affairs, LLC; AmgenCompletedMultiple MyelomaUnited States
-
Human Genome Sciences Inc., a GSK CompanyGlaxoSmithKlineCompletedCarcinoma, HepatocellularPuerto Rico, United States, Germany, Ukraine, Russian Federation, Poland, Romania
-
Janssen Research & Development, LLCActive, not recruiting
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaAustralia, Japan, Spain, Germany, Poland, Belgium, Israel, Italy, Russian Federation, Canada, New Zealand, Korea, Republic of, China, Brazil, Czechia, United States, Netherlands, United Kingdom, Greece, France
-
Peking Union Medical College HospitalXian-Janssen Pharmaceutical Ltd.Active, not recruitingAmyloidosis; SystemicChina
-
PETHEMA FoundationJanssen-Cilag, S.A.; Celgene-BMS; LIDESECNot yet recruiting
-
National Cancer Institute (NCI)Janssen Scientific Affairs, LLCRecruiting
-
Ascentage Pharma Group Inc.RecruitingMultiple Myeloma | AmyloidosisUnited States
-
University of California, San DiegoTakeda; Celgene; Janssen, LPActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
University of Alabama at BirminghamRecruitingMultiple MyelomaUnited States
-
Bristol-Myers SquibbActive, not recruitingMicrosatellite Stable Colorectal Cancer | Mismatch Repair Proficient Colorectal Cancer | Microsatellite Unstable Colorectal Cancer | Mismatch Repair Deficient Colorectal CancerUnited States, Australia, Belgium, Canada, Ireland, Italy, Spain, France
-
Fate TherapeuticsTerminatedAcute Myeloid Leukemia | Multiple Myeloma | Myeloma | AML, AdultUnited States
-
Children's National Research InstituteThe Hospital for Sick Children; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingSickle Cell DiseaseUnited States
-
PETHEMA FoundationRecruitingRefractory Multiple MyelomaSpain
-
Singapore General HospitalJanssen, LP; International Myeloma FoundationActive, not recruitingMultiple Myeloma | MyelomaSingapore
-
University Hospital, LilleJanssen, LP; Intergroupe Francophone du MyelomeCompletedMultiple MyelomaFrance, Belgium
-
Duke UniversityWithdrawnUse of Recombinant Hyaluronidase Human is Effective for the Use of Local Blocks for Eyelid's SurgeryUpper Eyelid SurgeryUnited States